Trial
NCT05338346
A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies
Phase ITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Antengene Discovery Limited
Collaborators
—
Condition
Advanced Solid Tumors
Intervention
ATG-018
Why stopped
Lack of efficacy of study compound
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-07-18